# Immucell Corp: filings

ICCC · Nasdaq · CIK 811641 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iccc.md) · [Financials](/companies/iccc/financials.md) · [Filings](/companies/iccc/filings.md) · [Insiders](/companies/iccc/insiders.md)

## Reports and events: 335 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 214, 4 151, 10-Q 53, 10-K 18, DEF 14A 18, 3 14, SC 13D/A 12, 424B5 7, 4/A 7, 10-Q/A 6, PRE 14A 6, CORRESP 5, SC 13D 5, SC 13G/A 5, UPLOAD 5, 8-K/A 4, EFFECT 4, S-3 4, ARS 3, S-8 3, SC 13G 3, 10-K/A 2, 424B2 2, 424B3 2, S-3/A 2, SCHEDULE 13D/A 2, 3/A 1, 5 1, CT ORDER 1, D 1, DEFA14A 1, DEFR14A 1, NT 10-Q 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 10:01 ET | [8-K](/filings/0001437749-26-032465.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-032465 |
| 2026-08-13 | 20:08 ET | [10-Q](/filings/0001437749-26-027668.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027668 |
| 2026-08-13 | 20:07 ET | [8-K](/filings/0001437749-26-027667.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027667 |
| 2026-07-09 | 20:08 ET | [8-K](/filings/0001437749-26-023199.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-023199 |
| 2026-06-17 | 18:19 ET | [8-K](/filings/0001437749-26-020926.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020926 |
| 2026-06-10 | 20:05 ET | [8-K](/filings/0001437749-26-020154.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-020154 |
| 2026-05-14 | 20:09 ET | [8-K](/filings/0001437749-26-017049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017049 |
| 2026-05-14 | 20:07 ET | [10-Q](/filings/0001437749-26-017045.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017045 |
| 2026-05-13 | 20:07 ET | [10-K/A](/filings/0001437749-26-016719.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-016719 |
| 2026-05-08 | 21:00 ET | [8-K](/filings/0001437749-26-015945.md) | 1.01 Entry into a material agreement | 0001437749-26-015945 |
| 2026-04-24 | 12:00 ET | [DEF 14A](/filings/0001437749-26-013234.md) | Proxy statement, period 2026-06-11 | 0001437749-26-013234 |
| 2026-04-14 | 23:18 ET | [8-K](/filings/0001437749-26-012182.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012182 |
| 2026-04-08 | 20:05 ET | [8-K](/filings/0001437749-26-011757.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-011757 |
| 2026-03-30 | 21:34 ET | [10-K](/filings/0001437749-26-010339.md) | Annual report, period 2025-12-31 | 0001437749-26-010339 |
| 2026-03-18 | 20:05 ET | [8-K](/filings/0001437749-26-008842.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-008842 |
| 2026-03-04 | 21:07 ET | [8-K](/filings/0001437749-26-006912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-006912 |
| 2026-02-09 | 21:07 ET | [8-K](/filings/0001437749-26-003514.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-003514 |
| 2026-02-02 | 22:22 ET | [8-K](/filings/0001437749-26-002685.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-002685 |
| 2026-01-08 | 21:13 ET | [8-K](/filings/0001437749-26-000885.md) | 2.02 Results of operations; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-000885 |
| 2025-12-29 | 13:00 ET | [8-K](/filings/0001437749-25-038773.md) | 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038773 |
| 2025-11-20 | 21:36 ET | [SCHEDULE 13D/A](/filings/0001193125-25-289897.md) | Ownership report, active investor, amended | 0001193125-25-289897 |
| 2025-11-13 | 21:08 ET | [10-Q](/filings/0001437749-25-034817.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034817 |
| 2025-11-13 | 21:07 ET | [8-K](/filings/0001437749-25-034819.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034819 |
| 2025-11-04 | 21:08 ET | [8-K](/filings/0001437749-25-033017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-033017 |
| 2025-10-07 | 20:06 ET | [8-K](/filings/0001437749-25-030631.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-030631 |
| 2025-09-30 | 20:05 ET | [8-K](/filings/0001437749-25-030110.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-030110 |
| 2025-08-25 | 12:00 ET | [8-K](/filings/0001213900-25-080110.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-080110 |
| 2025-08-14 | 20:06 ET | [10-Q](/filings/0001213900-25-076635.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076635 |
| 2025-08-14 | 20:05 ET | [8-K](/filings/0001213900-25-076633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076633 |
| 2025-08-12 | 20:21 ET | [8-K](/filings/0001213900-25-074983.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-25-074983 |
| 2025-07-09 | 12:00 ET | [8-K](/filings/0001213900-25-062192.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-062192 |
| 2025-06-25 | 19:48 ET | [8-K](/filings/0001213900-25-057768.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-057768 |
| 2025-06-17 | 18:49 ET | [8-K](/filings/0001213900-25-055144.md) | 5.07 Shareholder vote results | 0001213900-25-055144 |
| 2025-05-14 | 20:06 ET | [10-Q](/filings/0001213900-25-043287.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043287 |
| 2025-05-14 | 20:05 ET | [8-K](/filings/0001213900-25-043290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043290 |
| 2025-04-24 | 20:08 ET | [DEF 14A](/filings/0001213900-25-035059.md) | Proxy statement, period 2025-06-12 | 0001213900-25-035059 |
| 2025-04-08 | 20:05 ET | [8-K](/filings/0001213900-25-029914.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-029914 |
| 2025-04-07 | 20:05 ET | [8-K](/filings/0001213900-25-029407.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-029407 |
| 2025-03-28 | 20:05 ET | [10-K](/filings/0001013762-25-004072.md) | Annual report, period 2024-12-31 | 0001013762-25-004072 |
| 2025-02-25 | 21:05 ET | [8-K](/filings/0001213900-25-017067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-017067 |
| 2025-01-16 | 21:05 ET | [8-K](/filings/0001213900-25-004200.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-004200 |
| 2025-01-10 | 12:10 ET | [8-K](/filings/0001213900-25-002326.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-002326 |
| 2024-12-09 | 21:12 ET | [8-K](/filings/0001213900-24-106933.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-106933 |
| 2024-12-02 | 21:05 ET | [8-K](/filings/0001213900-24-104543.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-104543 |
| 2024-11-13 | 21:05 ET | [10-Q](/filings/0001213900-24-097450.md) | Quarterly report, period 2024-09-30 | 0001213900-24-097450 |
| 2024-11-13 | 21:05 ET | [8-K](/filings/0001213900-24-097449.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097449 |
| 2024-10-08 | 20:05 ET | [8-K](/filings/0001213900-24-086275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-086275 |
| 2024-09-24 | 15:55 ET | [8-K](/filings/0001213900-24-081304.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-081304 |
| 2024-09-17 | 17:49 ET | [SCHEDULE 13D/A](/filings/0001744329-24-000005.md) | Ownership report, active investor, amended | 0001744329-24-000005 |
| 2024-08-27 | 20:32 ET | [SC 13D](/filings/0001193125-24-207799.md) | Ownership report, active investor | 0001193125-24-207799 |

Page 1 of 7. [Older](/companies/iccc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.